E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil

MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability

Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209 · see citing works

A novel coronavirus from patients with pneumonia in China, 2019

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244 · see citing works

MRBAYES: Bayesian inference of phylogenetic trees.

Huelsenbeck, J. P., & Ronquist, F. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.8.754 · Cited by 21,937 · see citing works

PAML 4: Phylogenetic Analysis by Maximum Likelihood

Yang, Z. (2007) · Molecular Biology and Evolution · doi:10.1093/molbev/msm088 · Cited by 13,879 · see citing works

Posterior summarization in Bayesian phylogenetics using tracer 1.7

Rambaut, A., Drummond, A. J., Xie, D., Baele, G., & Suchard, M. A. (2018) · Systematic Biology · doi:10.1093/sysbio/syy032 · Cited by 11,159 · see citing works

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281 · see citing works

Unipro UGENE: a unified bioinformatics toolkit

Okonechnikov, K., Golosova, O., Fursov, M., & the UGENE team (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts091 · Cited by 3,181 · see citing works

GISAID: Global initiative on sharing all influenza data – from vision to reality

Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039 · see citing works

HyPhy: hypothesis testing using phylogenies

Pond, S. L. K., Frost, S. D. W., & Muse, S. V. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti079 · Cited by 2,866 · see citing works

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0770-5 · Cited by 2,543 · see citing works

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa

Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2020) · doi:10.1101/2020.12.21.20248640 · Cited by 2,535 · cited 8× · see citing works

Detection of a SARS-CoV-2 variant of concern in South Africa

Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03402-9 · Cited by 2,510 · see citing works

Not So Different After All: A Comparison of Methods for Detecting Amino Acid Sites Under Selection

Pond, S. L. K., & Frost, S. D. W. (2005) · Molecular Biology and Evolution · doi:10.1093/molbev/msi105 · Cited by 2,320 · see citing works

ModelTest-NG: A New and Scalable Tool for the Selection of DNA and Protein Evolutionary Models

Darriba, D., Posada, D., Kozlov, A. M., Stamatakis, A., Morel, B., & Flouri, T. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz189 · Cited by 2,128 · see citing works

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.012 · Cited by 1,956 · see citing works

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2349-y · Cited by 1,885 · see citing works

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Chi, X., Yan, R., Zhang, J., Zhang, G., Zhang, Y., Hao, M., Zhang, Z., Fan, P., Dong, Y., Yang, Y., et al. (2020) · Science · doi:10.1126/science.abc6952 · Cited by 1,385 · see citing works

FUBAR: A Fast, Unconstrained Bayesian AppRoximation for Inferring Selection

Murrell, B., Moola, S., Mabona, A., Weighill, T., Sheward, D. J., Pond, S. L. K., & Scheffler, K. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst030 · Cited by 1,368 · see citing works

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., et al. (2020) · eLife · doi:10.7554/elife.61312 · Cited by 1,308 · see citing works

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., et al. (2020) · Science · doi:10.1126/science.abd0831 · Cited by 1,253 · see citing works

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Wibmer, C. K., Ayres, F., Hermanus, T., Madzivhandila, M., Kgagudi, P., Oosthuysen, B., Lambson, B. E., de Oliveira, T., Vermeulen, M., van der Berg, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01285-x · Cited by 1,147 · see citing works

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Greaney, A. J., Starr, T. N., Gilchuk, P., Zost, S. J., Binshtein, E., Loes, A. N., Hilton, S. K., Huddleston, J., Eguia, R., Crawford, K. H. D., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.007 · Cited by 1,016 · see citing works

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006 · see citing works

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

Abu-Raddad, L. J., Chemaitelly, H., & Butt, A. A. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2104974 · Cited by 899 · see citing works

Less Is More: An Adaptive Branch-Site Random Effects Model for Efficient Detection of Episodic Diversifying Selection

Smith, M. D., Wertheim, J. O., Weaver, S., Murrell, B., Scheffler, K., & Pond, S. L. K. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv022 · Cited by 776 · see citing works

Emergence of genomic diversity and recurrent mutations in SARS-CoV-2

van Dorp, L., Acman, M., Richard, D., Shaw, L. P., Ford, C. E., Ormond, L., Owen, C. J., Pang, J., Tan, C. C. S., Boshier, F. A. T., et al. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104351 · Cited by 775 · see citing works

Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy

Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-Q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., et al. (2020) · Science · doi:10.1126/science.abc4730 · Cited by 762 · see citing works

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Xie, X., Liu, Y., Liu, J., Zhang, X., Zou, J., Fontes-Garfias, C. R., Xia, H., Swanson, K. A., Cutler, M., Cooper, D., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01270-4 · Cited by 628 · see citing works

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma

Andreano, E., Piccini, G., Licastro, D., Casalino, L., Johnson, N. V., Paciello, I., Monego, S. D., Pantano, E., Manganaro, N., Manenti, A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103154118 · Cited by 421 · see citing works

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

Jangra, S., Ye, C., Rathnasinghe, R., Stadlbauer, D., Alshammary, H., Amoako, A. A., Awawda, M. H., Beach, K. F., Bermúdez-González, M. C., Chernet, R. L., et al. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00068-9 · Cited by 385 · see citing works

Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil

Voloch, C. M., Silva F, R. D., de Almeida, L. G. P., Cardoso, C. C., Brustolini, O. J., Gerber, A. L., Guimarães, A. P. D. C., Mariani, D., Costa, R. M. D., Ferreira, O. C., et al. (2020) · doi:10.1101/2020.12.23.20248598 · Cited by 372 · see citing works

Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil

Voloch, C. M., da Silva Francisco, R., de Almeida, L. G. P., Cardoso, C. C., Brustolini, O. J., Gerber, A. L., Guimarães, A. P. D. C., Mariani, D., da Costa, R. M., Ferreira, O. C., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00119-21 · Cited by 372 · see citing works

The Evolution and Genetics of Virus Host Shifts

Longdon, B., Brockhurst, M. A., Russell, C. A., Welch, J. J., & Jiggins, F. M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004395 · Cited by 361 · see citing works

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19

Toyoshima, Y., Nemoto, K., Matsumoto, S., Nakamura, Y., & Kiyotani, K. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-0808-9 · Cited by 348 · see citing works

The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin

Xia, S., Lan, Q., Su, S., Wang, X., Xu, W., Liu, Z., Zhu, Y., Wang, Q., Lu, L., & Jiang, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0184-0 · Cited by 306 · see citing works

Evolutionary insights into host–pathogen interactions from mammalian sequence data

Sironi, M., Cagliani, R., Forni, D., & Clerici, M. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3905 · Cited by 302 · see citing works

Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy

Benvenuto, D., Angeletti, S., Giovanetti, M., Bianchi, M., Pascarella, S., Cauda, R., Ciccozzi, M., & Cassone, A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.058 · Cited by 257 · see citing works

Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China

Lu, J., du Plessis, L., Liu, Z., Hill, V., Kang, M., Lin, H., Sun, J., François, S., Kraemer, M. U. G., Faria, N. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.023 · Cited by 247 · see citing works

Augur: a bioinformatics toolkit for phylogenetic analyses of human pathogens

Huddleston, J., Hadfield, J., Sibley, T. R., Lee, J., Fay, K. A., Ilcisin, M., Harkins, E., Bedford, T., Neher, R. A., & Hodcroft, E. B. (2021) · The Journal of Open Source Software · doi:10.21105/joss.02906 · Cited by 237 · see citing works

Will SARS-CoV-2 variants of concern affect the promise of vaccines?

Gupta, R. K. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00556-5 · Cited by 204 · see citing works

Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission

Laha, S., Chakraborty, J., Das, S., Manna, S. K., Biswas, S., & Chatterjee, R. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104445 · Cited by 195 · see citing works

Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil

Nonaka, C. K. V., Franco, M. M., Gräf, T., Barcia, C. A. D. L., Mendonça, R. N. D. Á., de Sousa, K. A. F., Neiva, L. M. C., Fosenca, V., Mendes, A. V. A., Aguiar, R. S., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2705.210191 · Cited by 192 · see citing works

Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutantPreprint

Nelson, G., Buzko, O. V., Spilman, P., Niazi, K., Rabizadeh, S., & Soon‐Shiong, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.13.426558 · Cited by 175 · see citing works

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2

Yu, F., Xiang, R., Deng, X., Wang, L., Yu, Z., Tian, S., Liang, R., Li, Y., Ying, T., & Jiang, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00318-0 · Cited by 123 · see citing works

Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677Preprint

Hodcroft, E. B., Domman, D., Snyder, D. J., Oguntuyo, K. Y., Diest, M. V., Densmore, K. H., Schwalm, K. C., Femling, J., Carroll, J. L., Scott, R. S., et al. (2021) · medRxiv · doi:10.1101/2021.02.12.21251658 · Cited by 109 · see citing works

Genomic Evidence of a Sars-Cov-2 Reinfection Case With E484K Spike Mutation in BrazilPreprint

Nonaka, C. K. V., Franco, M. M., Gräf, T., Mendes, A. V. A., Aguiar, R. S., Giovanetti, M., & Souza, B. S. D. F. (2021) · Preprints.org · doi:10.20944/preprints202101.0132.v1 · Cited by 60 · see citing works

Modifiable lifestyle factors and severe COVID-19 risk: a Mendelian randomisation study

Li, S., & Hua, X. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00887-1 · Cited by 50 · see citing works

The COVID-19 pandemic and the true incidence of Tuberculosis in Japan

Komiya, K., Yamasue, M., Takahashi, O., Hiramatsu, K., Kadota, J.-I., & Kato, S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.07.004 · Cited by 49 · see citing works

ACE2 diversity in placental mammals reveals the evolutionary strategy of SARS-CoV-2

Fam, B. S. D. O., Vargas‐Pinilla, P., Amorim, C. E. G., Sortica, V. A., & Bortolini, M. C. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0104 · Cited by 34 · see citing works

SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation

Molina-Mora, J. A., Cordero-Laurent, E., Godínez, A., Calderón-Osorno, M., Brenes, H., Soto-Garita, C., Pérez-Corrales, C., Rica, C.-C. C. I. D. E. G. D. S.-C.-2. C., Drexler, J. F., Moreira‐Soto, A., et al. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104872 · Cited by 28 · see citing works

Positive selection drives a correlation between non-synonymous/synonymous divergence and functional divergence

Tennessen, J. A. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn205 · Cited by 27 · see citing works

Modifiable lifestyle factors and severe COVID-19 risk: Evidence from Mendelian randomization analysisPreprint

Li, S. (2020) · medRxiv · doi:10.1101/2020.10.19.20215525 · Cited by 4 · see citing works

SARS-CoV-2 escape <i>in vitro</i> from a highly neutralizing COVID-19 convalescent plasma

Andreano, E., Piccini, G., Licastro, D., Casalino, L., Johnson, N. V., Paciello, I., Monego, S. D., Pantano, E., Manganaro, N., Manenti, A., et al. (2020) · doi:10.1101/2020.12.28.424451 · cited 2×

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

Madhi, S. A., Baillie, V., Cutland, C. L., Voysey, M., Koen, A. L., Fairlie, L., Padayachee, S. D., Dheda, K., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102214 · Cited by 1,257 · see citing works

The biological and clinical significance of emerging SARS-CoV-2 variants

Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00408-x · Cited by 1,009 · see citing works

A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses

Tauzin, A., Nayrac, M., Benlarbi, M., Gong, S. Y., Gasser, R., Beaudoin-Bussières, G., Brassard, N., Laumaea, A., Vézina, D., Prévost, J., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.001 · Cited by 187 · see citing works

Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines

Focosi, D., & Maggi, F. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2231 · Cited by 148 · see citing works

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations

Chakraborty, C., Sharma, A. R., Bhattacharya, M., & Lee, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801522 · Cited by 150 · see citing works

Evolutionary trajectory of SARS-CoV-2 and emerging variants

Singh, J., Pandit, P., McArthur, A. G., Banerjee, A., & Mossman, K. L. (2021) · Virology Journal · doi:10.1186/s12985-021-01633-w · Cited by 144 · see citing works

Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies

Alenquer, M., Ferreira, F., Lousa, D., Valério, M., Medina-Lopes, M., Bergman, M., Gonçalves, J., Demengeot, J., Leite, R. B., Lilue, J., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009772 · Cited by 99 · see citing works

RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact

Vega‐Magaña, N., Sánchez-Sánchez, R., Hernández‐Bello, J., Venancio-Landeros, A. A., Rodríguez, M. P., Vega-Zepeda, R. A., Galindo-Ornelas, B., Díaz-Sánchez, M., García‐Chagollán, M., Ojeda, G. M., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.672562 · Cited by 67 · see citing works

In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools

Nag, A., Paul, S., Banerjee, R., & Kundu, R. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104818 · Cited by 50 · see citing works

Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants

Yang, Z. L., Zhang, S., Tang, Y., Zhang, S., Xu, D.-Q., Yue, S., & Liu, Q. (2022) · Aging and Disease · doi:10.14336/ad.2021.1210 · Cited by 44 · see citing works

Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco

Peng, J., Liu, J., Mann, S. A., Mitchell, A. M., Laurie, M. T., Sunshine, S., Pilarowski, G., Ayscue, P., Kistler, A., Vanaerschot, M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab283 · Cited by 41 · see citing works

A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responsesPreprint

Tauzin, A., Nayrac, M., Benlarbi, M., Gong, S. Y., Gasser, R., Beaudoin-Bussières, G., Brassard, N., Laumaea, A., Vézina, D., Prévost, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.18.435972 · Cited by 41 · see citing works

Novel and emerging mutations of SARS-CoV-2: Biomedical implications

Mohammadi, E., Shafiee, F., Shahzamani, K., Ranjbar, M. M., Alibakhshi, A., Ahangarzadeh, S., Beikmohammadi, L., Shariati, L., Hooshmandi, S., Ataei, B., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111599 · Cited by 38 · see citing works

Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil

Franceschi, V. B., Caldana, G., Mayer, A. D. M., Cybis, G., Neves, C. A. M., Ferrareze, P. A. G., Demoliner, M., de Almeida, P. R., Gularte, J. S., Hansen, A., et al. (2021) · BMC Genomics · doi:10.1186/s12864-021-07708-w · Cited by 38 · see citing works

Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual

Halfmann, P., Minor, N. R., Haddock, L. A., Maddox, R., Moreno, G. K., Braun, K. M., Baker, D. A., Riemersa, K. K., Prasad, A., Alman, K. J., et al. (2022) · Virus Evolution · doi:10.1093/ve/veac104 · Cited by 34 · see citing works

Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil

Zimerman, R. A., Ferrareze, P. A. G., Cadegiani, F., Wambier, C. G., Fonseca, D. D. N., de Souza, A. R., Goren, A., Rotta, L. N., Ren, Z., & Thompson, C. E. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.806611 · Cited by 32 · see citing works

Exploring the immune evasion of SARS-CoV-2 variant harboring E484K by molecular dynamics simulations

Wu, L., Peng, C., Yang, Y., Shi, Y., Zhou, L., Xu, Z., & Zhu, W. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab383 · Cited by 26 · see citing works

Understanding the molecular interaction of SARS-CoV-2 spike mutants with ACE2 (angiotensin converting enzyme 2)

Istıflı, E. S., Netz, P. A., Tepe, A. S., Sarıkürkçü, C., & Tepe, B. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1975569 · Cited by 24 · see citing works

Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021

Franceschi, V. B., Ferrareze, P. A. G., Zimerman, R. A., Cybis, G. B., & Thompson, C. E. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198532 · Cited by 25 · see citing works

Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms

Barona‐Gómez, F., Delaye, L., Díaz-Valenzuela, E., Plisson, F., Cruz‐Pérez, A., Díaz-Sánchez, M., García-Sepúlveda, C. A., Sánchez‐Flores, A., Abreu, R. P., Valencia-Valdespino, F. J., et al. (2021) · Microbial Genomics · doi:10.1099/mgen.0.000684 · Cited by 24 · see citing works

Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development

He, X., He, C., Hong, W., Yang, H. J., & Wei, X. (2023) · Medicinal Research Reviews · doi:10.1002/med.21941 · Cited by 24 · see citing works

Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants

Rais, Y., Fu, Z., & Drabovich, A. P. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09325-x · Cited by 21 · see citing works

Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy

Damavandi, A. R., Dowran, R., Sharif, S. A., Kashanchi, F., & Jafari, R. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00729-6 · Cited by 21 · see citing works

Introduction and rapid dissemination of SARS-CoV-2 Gamma Variant of Concern in Venezuela

Jaspe, R., Loureiro, C., Sulbarán, Y., Moros, Z., D'Angelo, P., Rodríguez, L., Zambrano, J. L., Hidalgo, M., Vizzi, E., Alarcón, V., et al. (2021) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2021.105147 · Cited by 13 · see citing works

Description of a One-Year Succession of Variants of Interest and Concern of SARS-CoV-2 in Venezuela

Jaspe, R. C., Loureiro, C. L., Sulbarán, Y. F., Moros, Z., D’Angelo, P., Hidalgo, M., Rodríguez, L., Alarcón, V., Aguilar, M., Sánchez, D., et al. (2022) · Viruses · doi:10.3390/v14071378 · Cited by 16 · see citing works

Epidemiology of COVID-19: An updated review.

Halaji, M., Heiat, M., Faraji, N., & Ranjbar, R. (2021) · PubMed Central · doi:10.4103/jrms.jrms_506_20 · Cited by 16 · see citing works

Insights into the mutation T1117I in the spike and the lineage B.1.1.389 of SARS-CoV-2 circulating in Costa Rica

Molina-Mora, J. A. (2022) · Gene Reports · doi:10.1016/j.genrep.2022.101554 · Cited by 16 · see citing works

Structural aspects of SARS-CoV-2 mutations: Implications to plausible infectivity with ACE-2 using computational modeling approach

Gopi, P., Gurnani, M., Singh, S., Sharma, P., & Pandya, P. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2108901 · Cited by 16 · see citing works

SARS-CoV-2 Variants: Mutations and Effective Changes

Park, G., & Hwang, B. H. (2021) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-021-0327-3 · Cited by 15 · see citing works

SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression

Hussein, H. A. M., Thabet, A. A., Wardany, A. A., El-Adly, A. M., Ali, M. E., Hassan, M. E. A., Abdeldayem, M. A. B., Mohamed, A.-R. M. A., Sobhy, A., El‐Mokhtar, M. A., et al. (2024) · Virology Journal · doi:10.1186/s12985-024-02342-w · Cited by 17 · see citing works

A novel diagnostic test to screen SARS-CoV-2 variants containing E484K and N501Y mutations

Zhao, Y., Lee, A., Composto, K., Cunningham, M. H., Mediavilla, J. R., Fennessey, S., Corvelo, A., Chow, K. F., Zody, M. C., Chen, L., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1929504 · Cited by 14 · see citing works

Predominance of the SARS-CoV-2 Lineage P.1 and Its Sublineage P.1.2 in Patients from the Metropolitan Region of Porto Alegre, Southern Brazil in March 2021

Franceschi, V. B., Caldana, G. D., Perin, C., Horn, A., Peter, C., Cybis, G. B., Ferrareze, P. A. G., Rotta, L. N., Cadegiani, F., Zimerman, R. A., et al. (2021) · Pathogens · doi:10.3390/pathogens10080988 · Cited by 13 · see citing works

SARS-CoV-2 integral membrane proteins shape the serological responses of patients with COVID-19

Martin, S., Heslan, C., Jégou, G., Eriksson, L. A., Gallo, M. L., Thibault, V., Chevet, É., Godey, F., & Avril, T. (2021) · iScience · doi:10.1016/j.isci.2021.103185 · Cited by 20 · see citing works

Evolutionary Traits and Genomic Surveillance of SARS-CoV-2 in South America

Ortíz-Pineda, P. A., & Sierra-Torres, C. H. (2022) · Global Health · doi:10.1155/2022/8551576 · Cited by 13 · see citing works

Global Prevalence of Adaptive and Prolonged Infections’ Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein

Lennerstrand, J., & Palanisamy, N. (2021) · Viruses · doi:10.3390/v13101974 · Cited by 12 · see citing works

Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses

Wang, R.-Y., Zhai, G., Zhu, G., Wang, M., Gong, X., Zhang, W.-D., Ge, G.-B., Chen, H., & Chen, L. (2022) · Bioorganic chemistry (Print) · doi:10.1016/j.bioorg.2022.106264 · Cited by 11 · see citing works

Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages

Mostefai, F., Gamache, I., N’Guessan, A., Pelletier, J., Huang, J., Murall, C. L., Pesaranghader, A., Gaonac’h-Lovejoy, V., Hamelin, D. J., Poujol, R., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.826746 · Cited by 11 · see citing works

Evolutionary history of the SARS-CoV-2 Gamma variant of concern (P.1): a perfect storm

Yépez, Y., Marcano-Ruiz, M., Bezerra, R. S., Fam, B., Ximenez, J. P., Silva, W. A., Jr., & Bortolini, M. C. (2022) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2021-0309 · Cited by 13 · see citing works

Efficacy of Proxalutamide in Hospitalized COVID-19 Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Clinical TrialPreprint

Cadegiani, F., Fonseca, D. D. N., McCoy, J. M., Zimerman, R. A., Mirza, F. N., Correia, M. D. N., Barros, R. N., Onety, D. C., Israel, K. C. P., de Almeida, B. G., et al. (2021) · medRxiv · doi:10.1101/2021.06.22.21259318 · Cited by 12 · see citing works

In vitro Study of Biological Properties of SARS-CoV-2 Coronavirus Strains Related to Various Genetic Variants

Zaykovskaya, A. V., Gladysheva, A. V., Kartashov, M. Y., Taranov, O. S., Ovchinnikova, A. S., Shipovalov, A. V., & Pyankov, O. V. (2022) · Problems of Particularly Dangerous Infections · doi:10.21055/0370-1069-2022-1-94-100 · Cited by 11 · see citing works

Evolutionary history of the SARS-CoV-2 Gamma variant of concern (P.1): a perfect storm

Mora, Y. B. Y., Marcano-Ruiz, M., Bezerra, R. D. S., Fam, B. S. D. O., Ximenez, J. P. B., Silva, W. A., & Bortolini, M. C. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 11 · see citing works

Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modalityPreprint

Goike, J., Hsieh, C., Horton, A. P., Gardner, E. C., Bartzoka, F., Wang, N., Javanmardi, K., Herbert, A. S., Abbasi, S. A., Renberg, R. L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.07.438849 · Cited by 11 · see citing works

Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants

Zimerman, R. A., Cadegiani, F., Costa, R. A. P. E., Goren, A., & de Souza, B. C. (2021) · Cureus · doi:10.7759/cureus.13819 · Cited by 8 · see citing works

Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage

Álvarez-Díaz, D. A., Laiton‐Donato, K., Torres, O., Ruiz-Moreno, H. A., Franco-Muñoz, C., Beltran, M. A., Mercado, M., Rueda, M. G., & Muñoz, A. L. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198629 · Cited by 8 · see citing works

Amino acids 484 and 494 of SARS-CoV-2 spike are hotspots of immune evasion affecting antibody but not ACE2 bindingPreprint

Alenquer, M., Ferreira, F., Lousa, D., Valério, M., Medina-Lopes, M., Bergman, M., Gonçalves, J., Demengeot, J., Leite, R. B., Lilue, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.22.441007 · Cited by 8 · see citing works

SARS-CoV2 Envelop Proteins Reshape the Serological Responses of COVID-19 PatientsPreprint

Martin, S., Heslan, C., Jégou, G., Eriksson, L. A., Gallo, M. L., Thibault, V., Chevet, É., Godey, F., & Avril, T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.15.431237 · Cited by 7 · see citing works

Deciphering the rule of antigen-antibody amino acid interaction

Jiang, M., Fang, C., & Ma, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1269916 · Cited by 6 · see citing works

A Simplified Sanger Sequencing Method for Detection of Relevant SARS-CoV-2 Variants

Deminco, F., Vaz, S. N., de Santana, D. S., Pedroso, C., Tadeu, J., Stöcker, A., Vieira, S. M., Netto, E. M., & Brites, C. R. (2022) · Diagnostics · doi:10.3390/diagnostics12112609 · Cited by 5 · see citing works

Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France

Colson, P., Fantini, J., Yahi, N., Delerce, J., Levasseur, A., Fournier, P., Lagier, J., Raoult, D., & Scola, B. L. (2022) · Archives of Virology · doi:10.1007/s00705-021-05331-4 · Cited by 4 · see citing works

An in silico pipeline approach uncovers a potentially intricate network involving spike SARS-CoV-2 RNA, RNA vaccines, host RNA-binding proteins (RBPs), and host miRNAs at the cellular level

Chetta, M., Tarsitano, M., Oro, M., Rivieccio, M., & Bukvić, N. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00413-5 · Cited by 5 · see citing works

Emerging Mutations Potentially Related to SARS-CoV-2 Immune Escape: The Case of a Long-Term Patient

Capozzi, L., Simone, D., Bianco, A., Sambro, L. D., Rondinone, V., Pace, L., Manzulli, V., Iacobellis, M., & Parisi, A. (2021) · Life · doi:10.3390/life11111259 · Cited by 4 · see citing works

Molecular evolution and structural analyses of the spike glycoprotein from Brazilian SARS-CoV-2 genomes: the impact of selected mutations

Ferrareze, P. A. G., Zimerman, R. A., Franceschi, V. B., Caldana, G. D., Netz, P. A., & Thompson, C. E. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2076154 · Cited by 4 · see citing works

Antibody isotype epitope mapping of SARS‐CoV‐2 Spike RBD protein: Targets for COVID‐19 symptomatology and disease control

Contreras, M., Vicente, J., Cerón, J. M. C., Martı́nez-Subiela, S., Urra, J. M., Rodríguez‐del‐Río, F. J., Ferreras‐Colino, E., Vaz‐Rodrigues, R., de Mera, I. G. F., Antunes, S., et al. (2023) · European Journal of Immunology · doi:10.1002/eji.202250206 · Cited by 4 · see citing works

Importance of mutations in amino acid 484 of the Spike protein of SARS-CoV-2: rapid detection by restriction enzyme analysis

Jaspe, R. C., Sulbarn, Y., Loureiro, C. L., D’Angelo, P., Rodríguez, L., Garzaro, D. J., Rangel, H. R., & Pujol, F. H. (2021) · Investigación Clínica · doi:10.22209/ic.v62s2a02 · Cited by 4 · see citing works

Las tecnologías de información y comunicación en el aprendizaje del estudiante en tiempos de COVID-19

Crispín, F. V. S., Tovar, M. T. B., Condori, F. R. H., Pelaiza, L. E. M., & Cajahuanca, J. E. V. (2021) · Boletín de Malariología y Salud Ambiental · doi:10.52808/bmsa.7e5.613.018 · Cited by 3 · see citing works

SARS-COV2 VARIANTS AND VACCINES MRNA SPIKES FIBONACCI NUMERICAL UA/CG METASTRUCTURES

Perez, J. C. (2021) · International Journal of Research -GRANTHAALAYAH · doi:10.29121/granthaalayah.v9.i6.2021.4040 · Cited by 3 · see citing works

THE INDIA MUTATIONS AND B.1.617 DELTA VARIANTS: IS THERE A GLOBAL "STRATEGY" FOR MUTATIONS AND EVOLUTION OF VARIANTS OF THE SARS-COV2 GENOME?

Perez, J. C. (2021) · International Journal of Research -GRANTHAALAYAH · doi:10.29121/granthaalayah.v9.i6.2021.4039 · Cited by 3 · see citing works

Spatiotemporal dissemination pattern of SARS-CoV-2 B1.1.28-derived lineages introduced into Uruguay across its southeastern border with BrazilPreprint

Rego, N., Fernández-Calero, T., Arantes, I., Noya, V., Mir, D., Brandes, M., Zanetti, J., Arleo, M., Pereira-Flores, E., Possi, T., et al. (2021) · medRxiv · doi:10.1101/2021.07.05.21259760 · Cited by 3 · see citing works

Data-driven approaches for genetic characterization of SARS-CoV-2 lineagesPreprint

Mostefai, F., Gamache, I., Huang, J., N’Guessan, A., Pelletier, J., Pesaranghader, A., Hamelin, D. J., Murall, C. L., Poujol, R., Grenier, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.28.462270 · Cited by 3 · see citing works

Substitution-Mutation Rate Ratio (c/µ) As Molecular Adaptation Test Beyond Ka/Ks: A SARS-COV-2 Case Study

Wu, C. F., Paradis, N. J., & Jain, K. (2025) · Journal of Molecular Evolution · doi:10.1007/s00239-025-10248-6 · Cited by 2 · see citing works

Genomic and virologic characterization of samples from a shipboard outbreak of COVID-19 reveals distinct variants within limited temporospatial parameters

Cer, R. Z., Voegtly, L. J., Adhikari, B. N., Pike, B. L., Lueder, M. R., Glang, L. A., Malagón, F., Ana, E. S., Regeimbal, J. M., Potts-Szoke, M. F., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.960932 · Cited by 2 · see citing works

Overview of diagnostic tools and nano-based therapy of SARS-CoV-2 infection

Bhattacharjee, B., Rynjah, D., Ahmed, A. B., Newar, A., Sengupta, S., Chakrabarty, S., Sahu, R. K., & Khan, J. (2024) · Chemical Papers · doi:10.1007/s11696-023-03271-8 · Cited by 2 · see citing works

SARS-CoV2 Variants and Vaccines mRNA Spikes Fibonacci Numerical UA/CG MetastructuresPreprint

Perez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0034.v5 · Cited by 2 · see citing works

SARS-CoV2 Variants and Vaccines mRNA Spikes Fibonacci Numerical UA/CG MetastructuresPreprint

Perez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0034.v4 · Cited by 2 · see citing works

SARS-CoV-2 Vaccinated Breakthrough Infections With Fatal and Critical Outcomes in the Department of Antioquia, ColombiaPreprint

Cardona, A., Villegas, S., Lopez, M. S., Maya, M. A., Ortiz-Restrepo, C., Hernandez-Ortiz, O., Ciuoderis, K., Pérez, L., Betancour, I., Muñoz, C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-963938/v1 · Cited by 2 · see citing works

Long COVID Optimal Health Programme to Enhance Mental and Physical Health: A Feasibility Randomised Controlled Trial

Al‐Jabr, H., Castle, D. J., Thompson, D. R., Windle, K., Belcher, J., Valenzuela, M. M. D. I., Helliwell, T., & Ski, C. F. (2025) · Health Expectations · doi:10.1111/hex.70399 · Cited by 1 · see citing works

Predominant Mutations of SARS-CoV-2: Their Geographical Distribution and Potential Consequences

Ünlü, S., Güçlü, A. Ü., & BAŞUSTAOĞLU, A. C. (2021) · Mediterranean Journal of Infection Microbes and Antimicrobials · doi:10.4274/mjima.galenos.2021.2021.15 · Cited by 1 · see citing works

COVID-19 Pandemic Global Dynamics, including Delayed Infections and the Emergence of New StrainsPreprint

de Souza, F. M. C. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3804374

The INDIA Mutations and B.1.617 Variant: Is There a Global "Strategy" for Mutations and Evolution of Variants of The SARS-CoV2 Genome?Preprint

Perez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0689.v1

SARS-CoV-2 convergent evolution cannot be reliably inferred from phylogenetic analysesPreprint

Jo, Y.-S., Tamuri, A. U., Towers, G. J., & Goldstein, R. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.15.444301

Peptidomimetic and Non- Peptidomimetic Derivatives as Possible SARS-CoV-2 Main Protease (Mpro) Inhibitors

Awadh, M. A. A., Ghatge, M. S., Alkhairi, M., Musayev, F. N., Donkor, A. K., Mughram, M. H. A., Omar, A. M., El‐Araby, M. E., & Safo, M. K. (2021) · VCU Scholars Compass (Virginia Commonwealth University)

Efficacy of Proxalutamide (GT0918) in Hospitalized COVID-19 PatientsPreprint

Cadegiani, F., Fonseca, D. D. N., McCoy, J. M., Zimerman, R. A., Mirza, F. N., Correia, M. D. N., Barros, R. N., Onety, D. C., Israel, K. C. P., de Almeida, B. G., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3866539

The INDIA Mutations and B.1.617 Variant: Is There a Global "Strategy" for Mutations and Evolution of Variants of The SARS-CoV2 Genome?Preprint

Perez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0689.v2

Predicting the Potential Effect of E484K Mutation on the Binding of 28 Antibodies to the Spike Protein of SARS-CoV-2 by Molecular Dynamics Simulation and Free Energy CalculationPreprint

Wu, L., Peng, C., Xu, Z., & Zhu, W. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13897091

ИЗОЛЯЦИЯ И ИЗУЧЕНИЕ IN VITRO БИОЛОГИЧЕСКИХ СВОЙСТВ ШТАММОВ КОРОНАВИРУСА SARS-COV-2, ОТНОСЯЩИХСЯ К РАЗЛИЧНЫМ ГЕНЕТИЧЕСКИМ ВАРИАНТАМPreprint

Зайковская, А., Gladysheva, A. V., Kartashov, M. Y., Taranov, O. S., Ovchinnikova, A. S., Shipovalov, A. V., & Пьянков, О. (2022) · doi:10.21055/preprints-3112046

Changes in Receptor Binding Domain of the Covid-19 during Pandemic; a Review Study

Jafari, M., Univercity, ‌. ‌., Ataee, R. A., Univercity, ‌. ‌., & Mahabadi, M. (2021) · Health Research Journal · doi:10.52547/hrjbaq.7.1.75

SARS-CoV2 Variants and Vaccines mRNA Spikes Fibonacci Numerical UA/CG MetastructuresPreprint

Perez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0034.v1

SARS-CoV2 Variants and Vaccines mRNA Spikes Fibonacci Numerical UA/CG MetastructuresPreprint

Perez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0034.v3

Impacto de la variante de interés Mu en la pandemia de COVID-19 en Colombia

Peña-López, B. O., Velásquez-Martínez, M. C., & Rincón‐Orozco, B. (2022) · Salud UIS · doi:10.18273/saluduis.54.e:22060

Protection of SARS-CoV-2 trial vaccines in human is a function of the viral genomes

Saganuwan, S. A. (2023) · RPS Pharmacy and Pharmacology Reports · doi:10.1093/rpsppr/rqad020

Investigation of COVID-19 virus mutagenicity and the effect of the NSP13, NSP14, and NSP16 on the -1 ribosomal frameshifting

Khanifar, A., Najafi, A., Hemmati, J., Nouri, F., Hosseini, S. A., & Taheri, M. (2024) · Frontiers in Virology · doi:10.3389/fviro.2024.1405680

Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021

Franceschi, V. B., Ferrareze, P. A. G., Zimerman, R. A., Cybis, G. B., & Thompson, C. E. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198532 · Cited by 25 · see citing works

Genomic Evidence of a Sars-Cov-2 Reinfection Case With E484K Spike Mutation in BrazilPreprint

Nonaka, C. K. V., Franco, M. M., Gräf, T., Mendes, A. V. A., Aguiar, R. S., Giovanetti, M., & Souza, B. S. D. F. (2021) · Preprints.org · doi:10.20944/preprints202101.0132.v1 · Cited by 60 · see citing works

A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil

Resende, P. C., Gräf, T., Paixão, A. C. D., Appolinario, L., Lopes, R. S., Mendonça, A. C. D. F., da Rocha, A. S. B., Motta, F. C., Neto, L. G. L., Khouri, R., et al. (2021) · Viruses · doi:10.3390/v13050724 · Cited by 43 · see citing works

Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil

Franceschi, V. B., Caldana, G., Mayer, A. D. M., Cybis, G., Neves, C. A. M., Ferrareze, P. A. G., Demoliner, M., de Almeida, P. R., Gularte, J. S., Hansen, A., et al. (2021) · BMC Genomics · doi:10.1186/s12864-021-07708-w · Cited by 38 · see citing works

Molecular evolution and structural analyses of the spike glycoprotein from Brazilian SARS-CoV-2 genomes: the impact of selected mutations

Ferrareze, P. A. G., Zimerman, R. A., Franceschi, V. B., Caldana, G. D., Netz, P. A., & Thompson, C. E. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2076154 · Cited by 4 · see citing works